Mechanisms of non-alcoholic steatohepatitis

Alcohol

Volumn 34, Issue 1, 2004, Pages 67-79

  McClain, Craig J ^a   Mokshagundam, Sri Prakash L ^a   Barve, Shirish S ^a   Song, Zhenyuan ^a   Hill, Daniell B ^a   Chen, Theresa ^a   Deaciuc, Ion ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cytokines; Fatty liver; Mitochondria; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

BIOACCUMULATION; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HEMOCONCENTRATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER TOXICITY; METABOLIC DISORDER; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; MOLECULAR MECHANICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL;

ALCOHOLISM; ANIMALS; FATTY LIVER; HUMANS; HYALURONIC ACID;

EID: 12844251988     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2004.07.007     Document Type: Conference Paper

References (101)

1. M.F. Abdelmalek, P. Angulo, R.A. Jorgensen, P.B. Sylvestre, and K.D. Lindor Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study Am J Gastroenterol 96 2001 2711 2717
2. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
3. M. Bajaj, S. Suraamornkul, P. Piper, L.J. Hardies, L. Glass, E. Cersosimo, T. Pratipanawatr, Y. Miyazaki, and R.A. DeFronzo Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients J Clin Endocrinol Metab 89 2004 200 206
4. M. Bajaj, S. Suraamornkul, T. Pratipanawatr, L.J. Hardies, W. Pratipanawatr, L. Glass, E. Cersosimo, Y. Miyazaki, and R.A. DeFronzo Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes Diabetes 52 2003 1364 1370
5. M.A. Banerji, M.C. Buckley, R.L. Chaiken, D. Gordon, H.E. Lebovitz, and J.G. Kral Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM Int J Obes Relat Metab Disord 19 1995 846 850
6. A.J. Barak, H.C. Beckenhauer, M.E. Mailliard, K.K. Kharbanda, and D.J. Tuma Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats J Nutr 133 2003 2845 2848
7. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med 7 2001 947 953
8. Boison, D., Scheurer, L., Zumsteg, V., Rülicke, T., Litynski, P., Fowler, B., Brandner, S., & Mohler, H. (Epub 7 May 2002). Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proceedings of the National Academy of Sciences of the United States of America. (For reader information: subsequent print publication, Proc Natl Acad Sci U S A 99, 6985-6990.)
9. E.M. Brunt Nonalcoholic steatohepatitis: definition and pathology Semin Liver Dis 21 2001 3 16
10. E. Bugianesi, P. Manzini, S. D'Antico, E. Vanni, F. Longo, N. Leone, P. Massarenti, A. Piga, G. Marchesini, and M. Rizzetto Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver Hepatology 39 2004 179 187
11. S.H. Caldwell, E.E. Hespenheide, J.A. Redick, J.C. Iezzoni, E.H. Battle, and B.L. Sheppard A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis Am J Gastroenterol 96 2001 519 525
12. N. Chalasani, D.W. Crabb, O.W. Cummings, P.Y. Kwo, A. Asghar, P.K. Pandya, and R.V. Considine Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 98 2003 2771 2776
13. N. Chalasani, M.A. Deeg, S. Persohn, and D.W. Crabb Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis Am J Gastroenterol 98 2003 1849 1855
14. K.D. Chavin, S. Yang, H.Z. Lin, J. Chatham, V.P. Chacko, J.B. Hoek, E. Walajtys-Rode, A. Rashid, C.-H. Chen, C.-C. Huang, T.-C. Wu, M.D. Lane, and A.M. Diehl Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion J Biol Chem 274 1999 5692 5700
15. R.K. Chawla, F.W. Lewis, M.H. Kutner, D.M. Bate, R.G. Roy, and D. Rudman Plasma cysteine, cystine, and glutathione in cirrhosis Gastroenterology 87 1984 770 776
16. R.K. Chawla, W.H. Watson, C.E. Eastin, E.Y. Lee, J. Schmidt, and C.J. McClain S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide- induced hepatic injury Am J Physiol Gastrointest Liver Physiol 275 1 Pt 1 1998 G125 G129
17. J. Chen, S. Schenker, T.A. Frosto, and G.I. Henderson Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits Biochim Biophys Acta 1380 1998 336 344
18. S. Chitturi, and G.C. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin Liver Dis 21 2001 27 41
19. S. Chitturi, and J. George Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis Curr Gastroenterol Rep 5 2003 18 25
20. B.E. Corkey, D.E. Hale, M.C. Glennon, R.I. Kelley, P.M. Coates, L. Kilpatrick, and C.A. Stanley Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome J Clin Invest 82 1988 782 788
21. H. Cortez-Pinto, M.E. Camilo, A. Baptista, A.G. De Oliveira, and M.C. De Moura Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 18 1999 353 358
22. H. Cortez-Pinto, J. Chatham, V.P. Chacko, C. Arnold, A. Rashid, and A.M. Diehl Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study JAMA 282 1999 1659 1664
23. J. Crespo, A. Cayón, P. Fernández-Gil, M. Hernández-Guerra, M. Mayorga, A. Domínguez-Díez, J.C. Fernández-Escalante, and F. Pons-Romero Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 34 2001 1158 1163
24. C.P. Day, and O.F.W. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845 (Editorial)
25. A.M. Duce, P. Ortiz, C. Cabrero, and J.M. Mato S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis Hepatology 8 1988 65 68
26. C.E. Eastin, C.J. McClain, E.Y. Lee, G.J. Bagby, and R.K. Chawla Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury Alcohol Clin Exp Res 21 1997 1037 1041
27. M.G. Emery, J.M. Fisher, J.Y. Chien, E.D. Kharasch, E.P. Dellinger, K.V. Kowdley, and K.E. Thummel CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease Hepatology 38 2003 428 435
28. Y. Falck-Ytter, Z.M. Younossi, G. Marchesini, and A.J. McCullough Clinical features and natural history of nonalcoholic steatosis syndromes Semin Liver Dis 21 2001 17 26
29. S. Fargion, M. Mattioli, A.L. Fracanzani, M. Sampietro, D. Tavazzi, P. Fociani, E. Taioli, L. Valenti, and G. Fiorelli Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis Am J Gastroenterol 96 2001 2448 2455
30. J.M. Fernández-Real, A. López-Bermejo, and W. Ricart Cross-talk between iron metabolism and diabetes Diabetes 51 2002 2348 2354
31. B. Fromenty, and D. Pessayre Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity Pharmacol Ther 67 1995 101 154
32. B. Fromenty, and D. Pessayre Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines J Hepatol 26 Suppl 2 1997 43 53
33. A. Garg, and A. Misra Hepatic steatosis, insulin resistance, and adipose tissue disorders J Clin Endocrinol Metab 87 2002 3019 3022 (Editorial)
34. J. George, N. Pera, N. Phung, I. Leclercq, J. Yun Hou, and G. Farrell Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis J Hepatol 39 2003 756 764
35. C. Grunfeld, M. Soued, S. Adi, A.H. Moser, C.A. Dinarello, and K.R. Feingold Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha Endocrinology 127 1990 46 54
36. 1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study Aliment Pharmacol Ther 15 2001 1667 1672
37. D.B. Hill, R. Devalaraja, S. Joshi-Barve, S. Barve, and C.J. McClain Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro Clin Biochem 32 1999 563 570
38. R. Honchel, M.B. Ray, L. Marsano, D. Cohen, E. Lee, S. Shedlofsky, and C.J. McClain Tumor necrosis factor in alcohol enhanced endotoxin liver injury Alcohol Clin Exp Res 16 1992 665 669
39. J.H. Horowitz, E.B. Rypins, J.M. Henderson, S.B. Heymsfield, S.D. Moffitt, R.P. Bain, R.K. Chawla, J.C. Bleier, and D. Rudman Evidence for impairment of transsulfuration pathway in cirrhosis Gastroenterology 81 1981 668 675
40. Y. Iimuro, R.M. Gallucci, M.I. Luster, H. Kono, and R.G. Thurman Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat Hepatology 26 1997 1530 1537
41. C. Ji, and N. Kaplowitz Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice Gastroenterology 124 2003 1488 1499
42. I. Jialal, and S. Devaraj Antioxidants and atherosclerosis: don't throw out the baby with the bath water Circulation 107 2003 926 928 (Editorial)
43. Keaney, J. F. Jr., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (Epub 30 January 2003). Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, Thrombosis, and Vascular Biology. (For reader information: subsequent print publication, Arterioscler Thromb Vasc Biol 23, 434-439.)
44. S.J. Kerr Competing methyltransferase systems J Biol Chem 247 1972 4248 4252
45. H. Knobler, A. Schattner, T. Zhornicki, S.D.H. Malnick, D. Keter, N. Sokolovskaya, Y. Lurie, and D.D. Bass Fatty liver - an additional and treatable feature of the insulin resistance syndrome QJM 92 1999 73 79
46. A. Koteish, and A.M. Diehl Animal models of steatohepatitis Best Pract Res Clin Gastroenterol 16 2002 679 690
47. M. Kugelmas, D.B. Hill, B. Vivian, L. Marsano, and C.J. McClain Cytokines and non-alcoholic steatohepatitis: a pilot study of the effects of lifestyle modification and vitamin E Hepatology 38 2003 413 419
48. J.E. Lavine Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study J Pediatr 136 2000 734 738
49. K.S. Lee, M. Buck, K. Houglum, and M. Chojkier Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression J Clin Invest 96 1995 2461 2468
50. Z. Li, S. Yang, H. Lin, J. Huang, P.A. Watkins, A.B. Moser, C. DeSimone, X.-y. Song, and A.M. Diehl Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343 350
51. C.S. Lieber Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases Adv Pharmacol 38 1997 601 628
52. H.Z. Lin, S.Q. Yang, C. Chuckaree, F. Kuhajda, G. Ronnet, and A.M. Diehl Metformin reverses fatty liver disease in obese, leptin-deficient mice Nat Med 6 2000 998 1003
53. S.C. Lu, L. Alvarez, Z.-Z. Huang, L. Chen, W. An, F.J. Corrales, M.A. Avila, G. Kanel, and J.M. Mato Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation Proc Natl Acad Sci U S A 98 2001 5560 5565
54. J. Ludwig, T.R. Viggiano, D.B. McGill, and B.J. Oh Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
55. F.H. Luyckx, P.J. Lefebvre, and A.J. Scheen Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss Diabetes Metab 26 2000 98 106
56. N.D. Manton, J. Lipsett, D.J. Moore, G.P. Davidson, A.J. Bourne, and R.T.L. Couper Non-alcoholic steatohepatitis in children and adolescents Med J Aust 173 2000 476 479
57. P. Marceau, S. Biron, F.-S. Hould, S. Marceau, S. Simard, S.N. Thung, and J.G. Kral Liver pathology and the metabolic syndrome X in severe obesity J Clin Endocrinol Metab 84 1999 1513 1517
58. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A.J. McCullough, S. Natale, G. Forlani, and N. Melchionda Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
59. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, M. Zoli, and N. Melchionda Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893 894
60. G. Marchesini, M. Brizi, A.M. Morselli-Labate, G. Bianchi, E. Bugianesi, A.J. McCullough, G. Forlani, and N. Melchionda Association of nonalcoholic fatty liver disease with insulin resistance Am J Med 107 1999 450 455
61. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, R. Manini, S. Natale, E. Vanni, N. Villanova, N. Melchionda, and M. Rizzetto Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
62. J.M. Mato, L. Alvarez, and J. Corrales S-adenosylmethionine and the liver I.M. Arias Liver: Biology and Pathobiology 1997 Raven Press New York 461 470
63. J.M. Mato, L. Alvarez, P. Ortiz, and M.A. Pajares S-adenosylmethionine synthesis: molecular mechanisms and clinical implications Pharmacol Ther 73 1997 265 280
64. J.M. Mato, J. Cámara, J. Fernández de Paz, L. Caballería, S. Coll, A. Caballero, L. García-Buey, J. Beltrán, V. Benita, J. Caballería, R. Solà, R. Moreno-Otero, F. Barrao, A. Martín-Duce, J.A. Correa, A. Parés, E. Barrao, I. García-Magaz, J.L. Puerta, J. Moreno, G. Boissard, P. Ortiz, and J. Rodés S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial J Hepatol 30 1999 1081 1089
65. J.M. Mato, F.J. Corrales, S.C. Lu, and M.A. Avila S-Adenosylmethionine: a control switch that regulates liver function FASEB J 16 2002 15 26
66. A.B. Mayerson, R.S. Hundal, S. Dufour, V. Lebon, D. Befroy, G.W. Cline, S. Enocksson, S.E. Inzucchi, G.I. Shulman, and K.F. Petersen The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes Diabetes 51 2002 797 802
67. C.J. McClain, S. Barve, I. Deaciuc, M. Kugelmas, and D. Hill Cytokines in alcoholic liver disease Semin Liver Dis 19 1999 205 219
68. C.J. McClain, and D.A. Cohen Increased tumor necrosis factor production by monocytes in alcoholic hepatitis Hepatology 9 1989 349 351
69. C.J. McClain, D.B. Hill, Z. Song, R. Chawla, W.H. Watson, T. Chen, and S. Barve S-Adenosylmethionine, cytokines, and alcoholic liver disease Alcohol 27 2002 185 192
70. R.A. Memon, K.R. Feingold, A.H. Moser, J. Fuller, and C. Grunfeld Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines Am J Physiol 274 2 Pt 1 1998 E210 E217
71. M.-H. Mendler, B. Turlin, R. Moirand, A.-M. Jouanolle, T. Sapey, D. Guyader, J.-Y. le Gall, P. Brissot, V. David, and Y. Deugnier Insulin resistance-associated hepatic iron overload Gastroenterology 117 1999 1155 1163
72. J.D. Morrow Is oxidant stress a connection between obesity and atherosclerosis? Arterioscler Thromb Vasc Biol 23 2003 368 370 (Editorial)
73. M. Nesher, and A. Boneh Effect of fatty acids and their acyl-CoA esters on protein kinase C activity in fibroblasts: possible implications in fatty acid oxidation defects Biochim Biophys Acta 1221 1994 66 72
74. B.A. Neuschwander-Tetri, E.M. Brunt, K.R. Wehmeier, D. Oliver, and B.R. Bacon Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone Hepatology 38 2003 1008 1017
75. O. Nygård, J.E. Nordrehaug, H. Refsum, P.M. Ueland, M. Farstad, and S.E. Vollset Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 1997 230 237
76. C.P.M.S. Oliveira, L.C. da Costa Gayotto, C. Tatai, B.I. Della Bina, M. Janiszewski, E.S. Lima, D.S.P. Abdalla, F.P. Lopasso, F.R.M. Laurindo, and A.A. Laudanna Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet J Cell Mol Med 6 2002 399 406
77. M. Palmer, and F. Schaffner Effect of weight reduction on hepatic abnormalities in overweight patients Gastroenterology 99 1990 1408 1413
78. M. Peréz-Carreras, P. Del Hoyo, M.A. Martín, J.C. Rubio, A. Martín, G. Castellano, F. Colina, J. Arenas, and J.A. Solis-Herruzo Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999 1007
79. K. Promrat, G. Lutchman, G.I. Uwaifo, R.J. Freedman, A. Soza, T. Heller, E. Doo, M. Ghany, A. Premkumar, Y. Park, T.J. Liang, J.A. Yanovski, D.E. Kleiner, and J.H. Hoofnagle A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis Hepatology 39 2004 188 196
80. M. Röhl, M. Pasparakis, S. Baudler, J. Baumgartl, D. Gautam, M. Huth, R. De Lorenzi, W. Krone, K. Rajewsky, and J.C. Brüning Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance J Clin Invest 113 2004 474 481
81. L. Ryysy, A.-M. Häkkinen, T. Goto, S. Vehkavaara, J. Westerbacka, J. Halavaara, and H. Yki-Järvinen Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients Diabetes 49 2000 749 758
82. E. Sanchez-Gongora, F. Ruiz, J. Mingorance, W. An, F.J. Corrales, and J.M. Mato Interaction of liver methionine adenosyltransferase with hydroxyl radical FASEB J 11 1997 1013 1019
83. Santamaría, E., Avila, M. A., Latasa, M. U., Rubio, A., Martín-Duce, A., Lu, S. C., Mato, J. M., & Corrales, F. J. (Epub 11 March 2003). Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proceedings of the National Academy of Sciences of the United States of America. (For reader information: subsequent print publication, Proc Natl Acad Sci U S A 100, 3065-3070.)
84. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling, V.A. Luketic, M.L. Shiffman, and J.N. Clore Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
85. B. Schwahn, and R. Rozen Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences Am J Pharmacogenomics 1 2001 189 201
86. Schwahn, B. C., Chen, Z., Laryea, M. D., Wendel, U., Lussier-Cacan, S., Genest, J. Jr., Mar, M.-H., Zeisel, S. H., Castro, C., Garrow, T., & Rozen, R. (Epub 22 January 2003). Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. (For reader information, subsequent print publication, FASEB J 17, 512-514.)
87. H.S.A. Sherratt Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit Trends Pharmacol Sci 7 1986 186 191
88. S.G. Sheth, F.D. Gordon, and S. Chopra Nonalcoholic steatohepatitis Ann Intern Med 126 1997 137 145
89. Z. Song, Z. Zhou, S. Uriarte, L. Wang, Y.J. Kang, T. Chen, S. Barve, and C.J. McClain S-adenosylhomocysteine sensitizes to TNF-α hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease Hepatology 40 2004 989 997
90. R. Sreekumar, B. Rosado, D. Rasmussen, and M. Charlton Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis Hepatology 38 2003 244 251
91. Y. Sumida, T. Nakashima, T. Yoh, M. Furutani, A. Hirohama, Y. Kakisaka, Y. Nakajima, H. Ishikawa, H. Mitsuyoshi, T. Okanoue, K. Kashima, H. Nakamura, and J. Yodoi Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease J Hepatol 38 2003 32 38
92. H. Tilg, and A.M. Diehl Cytokines in alcoholic and nonalcoholic steatohepatitis N Engl J Med 343 2000 1467 1476
93. T. Ueno, H. Sugawara, K. Sujaku, O. Hashimoto, R. Tsuji, S. Tamaki, T. Torimura, S. Inuzuka, M. Sata, and K. Tanikawa Therapeutic effects of restricted diet and exercise in obese patients with fatty liver J Hepatol 27 1997 103 107
94. A.J. Wigg, I.C. Roberts-Thomson, R.B. Dymock, P.J. McCarthy, R.H. Grose, and A.G. Cummins The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis Gut 48 2001 206 211
95. L. Wojtczak, and P. Schönfeld Effect of fatty acids on energy coupling processes in mitochondria Biochim Biophys Acta 1183 1993 41 57
96. A. Xu, Y. Wang, H. Keshaw, L.Y. Xu, K.S.L. Lam, and G.J.S. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J Clin Invest 112 2003 91 100
97. S.Q. Yang, H.Z. Lin, M.D. Lane, M. Clemens, and A.M. Diehl Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Natl Acad Sci U S A 94 1997 2557 2562
98. J.-M. Ye, M.A. Iglesias, D.G. Watson, B. Ellis, L. Wood, P.B. Jensen, R.V. Sørensen, P.J. Larsen, G.J. Cooney, K. Wassermann, and E.W. Kraegen PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly Am J Physiol Endocrinol Metab 284 2003 E531 E540
99. M. Yin, M.D. Wheeler, H. Kono, B.U. Bradford, R.M. Gallucci, M.I. Luster, and R.G. Thurman Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice Gastroenterology 117 1999 942 952
100. Z.M. Younossi, N. Boparai, L.L. Price, M.L. Kiwi, M. McCormick, and G. Guyatt Health-related quality of life in chronic liver disease: the impact of type and severity of disease Am J Gastroenterol 96 2001 2199 2205
101. V.A. Zammit Mechanisms of regulation of the partition of fatty acids between oxidation and esterification in the liver Prog Lipid Res 23 1984 39 67